Plummer-Vinson syndrome secondary prevention: Difference between revisions
Akshun Kalia (talk | contribs) |
Akshun Kalia (talk | contribs) No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Plummer-Vinson syndrome}} | {{Plummer-Vinson syndrome}} | ||
{{CMG}} {{AE}} | {{CMG}}; {{AE}}{{Akshun}} | ||
==Overview== | ==Overview== | ||
Patients of Plummer-Vinson syndrome are at a risk (10-15%) of developing [[malignant]] lesions ([[squamous cell carcinoma]]) of the [[oral mucosa]], [[hypopharynx]] and [[esophagus]]. Effective measures for the [[secondary prevention]] of Plummer-Vinson syndrome include an upper [[Gastrointestinal tract|gastrointestinal]] [[endoscopy]] every year to rule out [[malignant]] transformation. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
Patients of Plummer-Vinson syndrome are at a risk (10-15%) of developing malignant lesions of the oral mucosa, hypopharynx and esophagus. Effective measures for the secondary prevention of Plummer-Vinson syndrome include: | Patients of Plummer-Vinson syndrome are at a risk (10-15%) of developing [[malignant]] lesions ([[squamous cell carcinoma]]) of the [[oral mucosa]], [[hypopharynx]] and [[esophagus]]. Effective measures for the [[secondary prevention]] of Plummer-Vinson syndrome include:<ref name="pmid7575056">{{cite journal |vauthors=Hoffman RM, Jaffe PE |title=Plummer-Vinson syndrome. A case report and literature review |journal=Arch. Intern. Med. |volume=155 |issue=18 |pages=2008–11 |year=1995 |pmid=7575056 |doi= |url=}}</ref> | ||
*Upper gastrointestinal endoscopy | *Upper gastrointestinal [[endoscopy]] every year to rule out [[malignant]] transformation. | ||
==References== | ==References== | ||
Latest revision as of 19:01, 1 November 2017
|
Plummer-Vinson syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Plummer-Vinson syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Plummer-Vinson syndrome secondary prevention |
|
Risk calculators and risk factors for Plummer-Vinson syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]
Overview
Patients of Plummer-Vinson syndrome are at a risk (10-15%) of developing malignant lesions (squamous cell carcinoma) of the oral mucosa, hypopharynx and esophagus. Effective measures for the secondary prevention of Plummer-Vinson syndrome include an upper gastrointestinal endoscopy every year to rule out malignant transformation.
Secondary Prevention
Patients of Plummer-Vinson syndrome are at a risk (10-15%) of developing malignant lesions (squamous cell carcinoma) of the oral mucosa, hypopharynx and esophagus. Effective measures for the secondary prevention of Plummer-Vinson syndrome include:[1]